A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma

NCT00215956 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms

Interventions

DRUG: topotecan
PROCEDURE: radiation
PROCEDURE: surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]